“Lymphoma red flag”的搜索结果,显示 141-150 项,共有 9082 项
... lymphoma (B-LLy) when treated with ALL therapy without inotuzumab ozogamicin. Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a ...
... lymphoma (B-LLy) when treated with ALL therapy without inotuzumab ozogamicin. ... lymphoma (B-LLy) when treated with high-risk ALL chemotherapy. The ...
Multiple myeloma, Non-Hodgkin lymphoma, Hodgkin lymphoma, Small lymphocytic lymphoma, B-cell lymphoma, Follicular lymph...oma, Peripheral T-cell lymphoma ...
A Study To Evaluate VSV-hIFNbeta-NIS To Treat Patients With Relapsed/Refractory Multiple Myleoma, Acute Myeloid Leukemia, Or T-cell Lymphoma. Rochester, Minn ...
gov/types/lymphoma/patient/adult-nhl-treatment-pdq. Accessed Aug. 19, 2025. Hodgkin lymphoma treatment (PDQ) — Patient version. National Cancer Institute ...
查看妙佑医疗国际满意患者的故事。 Joanne-and-Paul-McDonnell-16-x-9-1024x576. New lymphoma therapy helps couple ...
The purpose of this study is to compare the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden.
This phase II trial studies the effect of ascorbic acid and combination chemotherapy in treating patients with lymphoma that has come back (recurrent) or does ...
on-Hodgkin lymphoma, Hodgkin lymphoma, Cutaneous t-cell lymphoma, Lymphoma, Small lymphocytic lymphoma, Cutaneous b-cell lymphoma, B-cell lymphoma, Diffuse ...
Testing The Addition Of Duvelisib Or CC-486 To The Usual Treatment For Peripheral T-Cell Lymphoma. Rochester, Minn. The purpose of this study is to evaluate ...
妙佑医疗国际不为任何公司或产品背书。广告收入为我们的非营利使命提供支持。
浏览妙佑医疗国际出版社提供的畅销书以及书籍和简报的特别优惠。
您的捐赠可以抵税。请您慷慨解囊,和我们一起进行尖端研究和医护,共同推动医学的改变。